Related Experiment Video
Updated: Aug 4, 2025

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
Published on: August 27, 2021
Generation and Characterization of Engineered Ubiquitin Variants to Modulate the Ubiquitin Signaling Cascade
Chen T Liang1, Olivia Roscow1, Wei Zhang2,3
1Department of Molecular and Cellular Biology, College of Biological Science, University of Guelph, Guelph, Ontario N1G2W1, Canada.
Abstract:
The ubiquitin signaling cascade plays a crucial role in human cells. Consistent with this, malfunction of ubiquitination and deubiquitination is implicated in the initiation and progression of numerous human diseases, including cancer. Therefore, the development of potent and specific modulators of ubiquitin signal transduction has been at the forefront of drug development. In the past decade, a structure-based combinatorial protein-engineering approach has been used to generate ubiquitin variants (UbVs) as protein-based modulators of multiple components in the ubiquitin-proteasome system. Here, we review the design and generation of phage-displayed UbV libraries, including the processes of binder selection and library improvement. We also provide a comprehensive overview of the general in vitro and cellular methodologies involved in characterizing UbV binders. Finally, we describe two recent applications of UbVs for developing molecules with therapeutic potential.
Insights
Researchers developed novel ubiquitin variants (UbVs) using protein engineering to modulate the ubiquitin system, offering potential new therapies for diseases like cancer by targeting ubiquitination pathways.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- The ubiquitin signaling cascade is vital in cellular functions, and its dysregulation is linked to diseases such as cancer.
- Targeting ubiquitination and deubiquitination pathways is a key strategy in developing new therapeutics.
- Protein-based modulators offer specificity and potency for modulating ubiquitin signal transduction.
Approach:
- Utilizing a structure-based combinatorial protein-engineering strategy to create ubiquitin variants (UbVs).
- Employing phage display technology for the generation and selection of UbV libraries.
- Developing and refining methods for UbV binder selection and library improvement.
Key Points:
- Detailed review of the design and generation of phage-displayed UbV libraries.
- Comprehensive overview of in vitro and cellular methodologies for characterizing UbV binders.
- Highlighting recent applications of UbVs in developing potential therapeutic molecules.
Conclusions:
- Ubiquitin variants (UbVs) represent a promising class of protein-based therapeutics.
- The presented approaches facilitate the development of specific modulators for the ubiquitin-proteasome system.
- UbV technology holds significant potential for future drug development targeting ubiquitin-related diseases.
More Related Videos
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...

